MyMD Pharmaceuticals Inc. buy melinda
Start price
17.01.18
/
50%
€105.60
Target price
18.01.18
€92.93
Performance (%)
0.00%
End price
18.01.18
€105.60
Summary
This prediction ended on 18.01.18 with a price of €105.60. melinda's BUY prediction for MyMD Pharmaceuticals Inc. closed unchanged from the start price. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| MyMD Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% | 65.292% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% | 97.467% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% | 39.755% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% | 61.093% |
Comments by melinda for this prediction
In the thread MyMD Pharmaceuticals Inc. diskutieren
AKERS
Akers Biosciences ein hervorragendes zweites Quartal hat den Umsatz um 25% gegenüber dem Vorjahr
Aktie
Der Umsatz belief sich US $ 1,2 Millionen für die drei Monate zum 30. Juni bis etwa 25% im Vergleich zum gleichen Zeitraum des Vorjahres und das 1,8 - fache der Figur Geschäft im ersten Quartal.
Stopped prediction by melinda for MyMD Pharmaceuticals Inc.
MyMD Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.12
12.11.22
12.11.22
€280.00
12.11.23
12.11.23
-87.36%
13.11.23
13.11.23
MyMD Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€3.96
10.10.20
10.10.20
€5.00
04.11.21
04.11.21
102.02%
05.11.21
05.11.21
MyMD Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€26.84
26.05.19
26.05.19
€56.28
10.10.20
10.10.20
-85.25%
10.10.20
10.10.20
MyMD Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€346.37
12.08.17
12.08.17
€519.55
19.12.17
19.12.17
-86.10%
19.12.17
19.12.17
MyMD Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€384.00
12.08.17
12.08.17
€576.00
19.12.17
19.12.17
-86.10%
19.12.17
19.12.17
MyMD Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€545.53
03.05.17
03.05.17
€623.46
16.05.17
16.05.17
-3.21%
16.05.17
16.05.17